The R&D budget for Health and Medical Sciences in Germany is forecasted to grow steadily from 2024 through 2028, with values increasing from 16.79% in 2024 to 17.81% in 2028 of the Total Government Budget Appropriation or Outlays for R&D (GBARD). This represents a compounded annual growth rate (CAGR) of approximately 1.48% over these five years. The year-on-year growth is modest, indicative of a consistent investment in the sector. In 2023, the budget stood at 16.55%, reflecting a steady upward trend in research funding allocations.

Future trends to watch for include:

Increased focus on digital health innovations and biotech advancements.
Potential shifts in funding priorities due to regulatory changes or public health needs.
Growing collaboration between public institutions and private entities to leverage resources and technology effectively.